Science Explorer Back to mapMap
Discussion
Researcher · Amgen (United States) · United States

David L. Lacey

David L. Lacey publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as Bone Metabolism and Diseases, Bone health and treatments and Bone health and osteoporosis research.

OpenAlex
World rank
#71,965
of 7,710,434 ranked researchers
Rank in United States
#27,774
of 1,627,098
Works
121
Citations
43k
Citations per work
359.1
h-index
64
i10-index 103Top 1.6% in Molecular Biology
David L. Lacey

What does David L. Lacey research?

David L. Lacey's work is mostly in Medicine (32%), Biochemistry, Genetics and Molecular Biology (23%), Immunology and Microbiology (8%).

Everything else: 45 works · 37.4% of their workHealth Sciences: 38 works · 31.5% of their workMedicine: 38 works · 31.5% of their workOncology: 19 works · 16.0% of their workOrthopedics and Sports Medicine: 8 works · 6.6% of their workHematology: 6 works · 4.6% of their workSurgery: 5 works · 4.3% of their workLife Sciences: 38 works · 31.1% of their workBiochemistry, Genetics and Molecular Biology: 28 works · 23.4% of their workMolecular Biology: 28 works · 23.4% of their workImmunology and Microbiology: 9 works · 7.7% of their workImmunology: 9 works · 7.7% of their workTHEIR WORKDavid L. Lacey121works
Life Sciences31%Health Sciences32%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else4537.4%
    1. Medicine3831.5%
    1. Biochemistry, Genetics and Molecular Biology2823.4%
    2. Immunology and Microbiology97.7%
  1. 1Molecular Biology23% of their works
  2. 2Oncology16% of their works
  3. 3Immunology8% of their works
  4. 4Orthopedics and Sports Medicine7% of their works
  5. 5Hematology5% of their works
  6. 6Surgery4% of their works

Research topics

Which keywords describe David L. Lacey's research?

The keywords of their largest research topics: Bone Resorption, Osteoclast Differentiation, Bisphosphonates, Osteonecrosis of the Jaw, Inflammation, Cancer, Bone Mineral Density and Fractures.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Bone Resorption491 topic
  2. Osteoclast Differentiation491 topic
  3. Bisphosphonates381 topic
  4. Osteonecrosis of the Jaw381 topic
  5. Inflammation313 topics
  6. Cancer303 topics
  7. Bone Mineral Density211 topic
  8. Fractures211 topic
  9. Signaling212 topics
  10. Immunity111 topic
  11. NF-?B111 topic
  12. Pattern Recognition Receptors111 topic
  13. Toll-like Receptors111 topic
  14. FGF21101 topic
  15. Fibroblast Growth Factor101 topic
  16. IL-691 topic
  17. STAT391 topic
  18. Bone Marrow Niche81 topic
  19. Hematopoietic Stem Cells81 topic

Where does David L. Lacey work?

David L. Lacey's main affiliation in the publication record is Amgen (United States), United States.

How many publications and citations does David L. Lacey have?

OpenAlex counts 121 works and 43,449 citations for David L. Lacey, an h-index of 64, ranking #71,965 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about David L. Lacey. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.